Laidlaw Wealth Management LLC Gilead Sciences, Inc. Transaction History

Laidlaw Wealth Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $6,960 - $7,893	95 Added 2.9%	3,369 $272,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $8,503 - $9,277	115 Added 3.64%	3,274 $245,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $59,895 - $68,319	-788 Reduced 19.96%	3,159 $243,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $13,606 - $15,502	-176 Reduced 4.27%	3,947 $327,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $20,814 - $29,882	-334 Reduced 7.49%	4,123 $353,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $27,150 - $31,012	-456 Reduced 9.28%	4,457 $275,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $2,481 - $2,795	43 Added 0.88%	4,913 $304,000
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $7,587 - $9,507	131 Added 2.76%	4,870 $290,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $307,466 - $348,979	4,739 New	4,739 $344,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $221,580 - $252,822	-3,693 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $209,208 - $238,383	3,693 New	3,693 $215,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $252,466 - $293,160	-3,490 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $218,578 - $279,967	3,490 New	3,490 $261,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.